This invention relates to novel processes for preparing the pharmaceutically active compound 5-(3-[(2S)-exo-bicyclo[2.2.1]hept-2-yloxy]-4-methoxyphenyl)-3,4,5,6-tetrahydropyrimidin-2(1H)-one and its corresponding 2R enantiomer and for preparing certain intermediates used in the synthesis of these compounds. It also relates to novel intermediates used in the synthesis of such pharmaceutically active compounds and to other novel compounds that are related to such intermediates.
这项发明涉及制备药用活性化合物5-(3-[(2S)-外消旋双环[2.2.1]庚-2-氧基]-4-
甲氧基苯基)-3,4,5,6-四氢
嘧啶-2(1H)-酮及其对应的2R对映体的新工艺,以及制备用于合成这些化合物的某些中间体。它还涉及用于合成此类药用活性化合物的新中间体,以及与这些中间体相关的其他新化合物。